DrugPatentWatch Database Preview
Drugs in Development Information for PF-04457845
Development status for investigational drug PF-04457845: Sponsors, patents, clinical trial progress
PF-04457845 is an investigational drug.
There have been 9 clinical trials for PF-04457845.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Chronic Pain, Stress Disorders, Post-Traumatic, and Acute Pain. The leading clinical trial sponsors are Pfizer, Yale University, and National Institute on Drug Abuse (NIDA).
There are four US patents protecting this investigational drug and ninety-two international patents.
Summary for PF-04457845
| US Patents | 4 |
| International Patents | 92 |
| US Patent Applications | 5 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2009-11-01) |
| Vendors | 38 |
Recent Clinical Trials for PF-04457845
| Title | Sponsor | Phase |
|---|---|---|
| A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder | Pfizer | Phase 2 |
| FAAH Inhibitor Trial for Adults With Tourette Syndrome | Tourette Association of America | Phase 2 |
| FAAH Inhibitor Trial for Adults With Tourette Syndrome | Yale University | Phase 2 |
Clinical Trial Summary for PF-04457845
Top disease conditions for PF-04457845
Top clinical trial sponsors for PF-04457845
US Patents for PF-04457845
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| PF-04457845 | See Pricing | Biaryl ether urea compounds | Pfizer Inc. (New York, NY) | See Pricing |
| PF-04457845 | See Pricing | Sulfonamide derivatives | Pfizer Limited (Sandwich, GB) Icagen, Inc. (Durham, NC) | See Pricing |
| PF-04457845 | See Pricing | Sulfonamide derivatives | Pfizer Limited (Sandwich, GB) Icagen, Inc. (Durham, NC) | See Pricing |
| PF-04457845 | See Pricing | Sulfonamide derivatives | Pfizer Limited (Sandwich, GB) Icagen, Inc. (Durham, NC) | See Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for PF-04457845
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| PF-04457845 | African Regional IP Organization (ARIPO) | 2780 | 2026-10-18 | See Pricing |
| PF-04457845 | Argentina | 063331 | 2026-10-18 | See Pricing |
| PF-04457845 | Austria | 493984 | 2026-10-18 | See Pricing |
| PF-04457845 | Australia | 2007311591 | 2026-10-18 | See Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
